Erik Magnusson appointed new Chief Financial Officer (CFO) in Emplicure AB.
Emplicure announces today that the company has appointed Erik Magnusson as new CFO, starting January 1 2022. He succeeds Anna-Lena Nicolson, whose contract expires December 31.
"The company is in an exiting phase of growth where Erik's background and experience will be a strong contribution to the development of Emplicure" says Torbjörn W Larsson, CEO at Emplicure.
Erik brings over 25 years of combined experience in financial planning and operations, investor relations, and economic consulting, where he has held financial management positions within i.e. Systembolaget, Aleris, and Coop. He also has background as financial analyst, covering the Nordic medtech and hospital sector at ABG Sundal Collier, among others. Erik will be working part time and will initially work in tandem with Anna-Lena during December to secure a seamless transition.
Certified Adviser is Mangold Fondkommission AB, +46 8 503 015 50, or via firstname.lastname@example.org
This information is information that Emplicure AB (publ) is obliged to disclose pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The informationen was submitted for publication, through the agency of the contact person above, on November 25, 2021 at 11:15 AM CET.
Emplicure is a pharmaceutical company developing new and innovative drugs by combining existing and approved active substances, and advanced materials science within ceramic biomaterials. The product portfolio is focused on chronic pain, and with abuse deterrent formulations. The wholly owned subisidiary, Amplicon AB develops consumer products, with tobacco-free nicotine as the first product. Read more at www.emplicure.com